دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Towards equitable access to treatment for multiple sclerosis
doi : 10.1016/S1474-4422(23)00041-8
Volume 22, Issue 3, March 2023, Page 189
A nasal CGRP receptor antagonist for acute migraine therapy
Uwe Reuter
doi : 10.1016/S1474-4422(23)00037-6
Volume 22, Issue 3, March 2023, Pages 190-191
Antisense oligonucleotides in myotonic dystrophy type 1: lessons learnt
Valeria A Sansone
doi : 10.1016/S1474-4422(23)00040-6
Volume 22, Issue 3, March 2023, Pages 191-192
MOGAD comes of age with new criteria
Francesc Graus, *Josep Dalmau
doi : 10.1016/S1474-4422(22)00520-8
Volume 22, Issue 3, March 2023, Pages 193-194
Macrophages clear the way for CNS fluid flow
Steven T Proulx, *Britta Engelhardt
doi : 10.1016/S1474-4422(23)00028-5
Volume 22, Issue 3, March 2023, Pages 194-195
With thanks to our peer reviewers in 2022
Laura Hart
doi : 10.1016/S1474-4422(23)00042-X
Volume 22, Issue 3, March 2023, Page 196
Thank you to The Lancet Neurology's peer reviewers in 2022
doi : 10.1016/S1474-4422(23)00024-8
Volume 22, Issue 3, March 2023, Pages e1-e4
Treatment of asymptomatic carotid stenosis in SPACE-2
*Akshit Goel, Iris Soteriou,
doi : 10.1016/S1474-4422(23)00025-X
Volume 22, Issue 3, March 2023, Page 197
Treatment of asymptomatic carotid stenosis in SPACE-2
J David Spence
doi : 10.1016/S1474-4422(23)00033-9
Volume 22, Issue 3, March 2023, Pages 197-198
Treatment of asymptomatic carotid stenosis in SPACE-2 – Authors' reply
Tilman Reiff, Hans-Henning Eckstein, Ulrich Mansmann, Werner Hacke, Peter Arthur Ringleb
doi : 10.1016/S1474-4422(23)00030-3
Volume 22, Issue 3, March 2023, Pages 198-199
Extended-interval dosing of natalizumab in NOVA
Olaf Stüve, *Bastian Tugemann
doi : 10.1016/S1474-4422(23)00032-7
Volume 22, Issue 3, March 2023, Pages 199-200
Extended-interval dosing of natalizumab in NOVA – Authors' reply
John F Foley, Nolan Campbell, George Kong
doi : 10.1016/S1474-4422(23)00034-0
Volume 22, Issue 3, March 2023, Pages 200-201
Treatment-induced neuropathy of diabetes: an underdiagnosed entity
Juan Eduardo Quiroz-Aldave, MarÃa del Carmen Durand-Vásquez, Susan Luciana Puelles-León, Luis Alberto Concepción-Urteaga, *Marcio José Concepción-Zavaleta
doi : 10.1016/S1474-4422(23)00029-7
Volume 22, Issue 3, March 2023, Pages 201-202
Treatment-induced neuropathy of diabetes: an underdiagnosed entity – Authors' reply
Melissa A Elafros, Masha G Savelieff, *Eva L Feldman
doi : 10.1016/S1474-4422(23)00035-2
Volume 22, Issue 3, March 2023, Page 202
Urgent need for neurological care in Ukraine
Luke D Tomycz, Christopher Markosian, Oleksandr Strelko, Andrii Sirko, Mykhailo Lovha, Rocco A Armonda, on behalf of contributors to Razom Health
doi : 10.1016/S1474-4422(23)00026-1
Volume 22, Issue 3, March 2023, Pages 202-203
Correction to Lancet Neurol 2022; 21: 1099–109
doi : 10.1016/S1474-4422(23)00048-0
Volume 22, Issue 3, March 2023, Page e5
A spirited community that knows how to fight
Jules Morgan
doi : 10.1016/S1474-4422(23)00043-1
Volume 22, Issue 3, March 2023, Pages 204-205
Pierre Amarenco: the persistent pioneer
Udani Samarasekera
doi : 10.1016/S1474-4422(23)00044-3
Volume 22, Issue 3, March 2023, Page 206
Blue as an orange
Alexis Demas
doi : 10.1016/S1474-4422(23)00023-6
Volume 22, Issue 3, March 2023, Page 207
A chilly tale of dementia
Jules Morgan
doi : 10.1016/S1474-4422(22)00429-X
Volume 22, Issue 3, March 2023, Page 208
Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trial
Richard B Lipton, Robert Croop, David A Stock, Jennifer Madonia, Micaela Forshaw, Meghan Lovegren, Linda Mosher, Vladimir Coric, Peter J Goadsby
doi : 10.1016/S1474-4422(22)00517-8
Volume 22, Issue 3, March 2023, Pages 209-217
Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1/2a trial
Charles A Thornton, Richard Thomas Moxley III, Katy Eichinger, Chad Heatwole, Laurence Mignon, W David Arnold, Tetsuo Ashizawa, John W Day, Gersham Dent, Matthew K Tanner, Tina Duong, Ericka P Greene, Laura Herbelin, Nicholas E Johnson, Wendy King, John T Kissel, Doris G Leung, Donovan J Lott, Daniel A Norris, Evan M Pucillo, Wendy Schell, Jeffrey M Statland, Nikia Stinson, Sub H Subramony, Shuting Xia, Kathie M Bishop, C Frank Bennett
doi : 10.1016/S1474-4422(23)00001-7
Volume 22, Issue 3, March 2023, Pages 218-228
Towards functional improvement of motor disorders associated with cerebral palsy
Saranda Bekteshi, Elegast Monbaliu, Sarah McIntyre, Gillian Saloojee, Sander R Hilberink, Nana Tatishvili, Bernard Dan
doi : 10.1016/S1474-4422(23)00004-2
Volume 22, Issue 3, March 2023, Pages 229-243
Prediction of autism in infants: progress and challenges
Geraldine Dawson, Amber D Rieder, Mark H Johnson
doi : 10.1016/S1474-4422(22)00407-0
Volume 22, Issue 3, March 2023, Pages 244-254
Carpal tunnel syndrome: updated evidence and new questions
Luca Padua, Cristina Cuccagna, Silvia Giovannini, Daniele Coraci, Luciana Pelosi, Claudia Loreti, Roberto Bernabei, Lisa D Hobson-Webb
doi : 10.1016/S1474-4422(22)00432-X
Volume 22, Issue 3, March 2023, Pages 255-267
Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria
Brenda Banwell*, Jeffrey L Bennett*, Romain Marignier*, Ho Jin Kim*, Fabienne Brilot, Eoin P Flanagan, Sudarshini Ramanathan, Patrick Waters, Silvia Tenembaum, Jennifer S Graves, Tanuja Chitnis, Alexander U Brandt, Cheryl Hemingway, Rinze Neuteboom, Lekha Pandit, Markus Reindl, Albert Saiz, Douglas Kazutoshi Sato, Kevin Rostasy*, Friedemann Paul*, Sean J Pittock*, Kazuo Fujihara*, Jacqueline Palace
doi : 10.1016/S1474-4422(22)00431-8
Volume 22, Issue 3, March 2023, Pages 268-282
